SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Lancet Diabetes Endocrinol. 2016;4(1):27-34.

10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study.

, , , , , ,

제1저자 온정헌 · 교신저자 박경수,조남하

PMID 26577716 DOI 10.1016/S2213-8587(15)00336-8 IF 36.3 내분비대사내과
소속 (4)
  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
  2. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea. Electronic address: kspark@snu.ac.kr.
  4. Department of Preventive Medicine, Ajou University School of Medicine, Suwon, South Korea. Electronic address: chnaha@ajou.ac.kr.

Abstract

BACKGROUND The relative contributions of β-cell function and insulin sensitivity in the pathogenesis of type 2 diabetes are not fully understood. We investigated the longitudinal change in β-cell function and insulin sensitivity in the development of diabetes and the role of genetic variants in deterioration of glucose tolerance.

METHODS We followed up 4106 participants with normal glucose tolerance (NGT) from the Korean Genome and Epidemiology Study with oral glucose tolerance tests every 2 years for 10 years. We estimated pancreatic β-cell function with the 60 min insulinogenic index (IGI60) and insulin sensitivity with the composite (Matsuda) insulin sensitivity index (ISI). We investigated the association of 66 known type 2 diabetes genetic variants with risk of prediabetes or diabetes and impaired β-cell function and insulin sensitivity.

FINDINGS During 10 years of follow-up, 1093 (27%) of 4106 participants developed prediabetes and 498 (12%) participants developed diabetes. Compared with participants who remained NGT, those who progressed to diabetes had a lower IGI60 (unadjusted data 5·1 μU/mmol [95% CI 0·5-56·1] vs 7·9 μU/mmol [0·5-113·8]; p<0·0001) and lower ISI (unadjusted data 8·2 [2·6-26·0] vs 10·0 [3·2-31·6]; p<0·0001) at baseline. Participants who had NGT at 10 years showed a decrease in ISI (adjusted data 10·1 [9·9-10·3] vs 7·4 [7·3-7·6]; p<0·0001) but a compensatory increase in IGI60 (adjusted data 6·9 μU/mmol [6·5-7·2] vs 11·7 μU/mmol [11·2-12·1]; p<0·0001) compared with baseline. By contrast, participants who developed diabetes showed a decrease in ISI (adjusted data 8·4 [8·0-8·7] vs 3·0 [2·8-3·2]; p<0·0001) but no significant compensatory increase (p=0·95) in IGI60. A genetic variant near the glucokinase gene (rs4607517) was significantly associated with progression to prediabetes or diabetes (hazard ratio 1·27, 1·16-1·38; p=1·70 × 10(-7)).

INTERPRETATION Decreased β-cell function, which might be determined partly by genetic factors, and impaired β-cell compensation for progressive decline in insulin sensitivity are crucial factors in the deterioration of glucose tolerance.

FUNDING South Korean Ministry of Health & Welfare.

Copyright © 2016 Elsevier Ltd. All rights reserved.

Comment · 정정

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
The lancet. Diabetes & endocrinology · eISSN 2213-8595
전자 출판
2015-11-11
MeSH
Adult · Aged · Blood Glucose / analysis · Diabetes Mellitus, Type 2 / blood / epidemiology / genetics / physiopathology · Disease Progression · Female · Glucose Tolerance Test · Humans · Insulin / blood · Insulin Resistance* / genetics · Insulin-Secreting Cells / physiology · Longitudinal Studies · Male · Middle Aged · Prospective Studies
Substances
Blood Glucose · Insulin